France Immuno Chemistry Market Outlook to 2021
Description-
Summary
GlobalDatas
new report, "France Immuno
Chemistry
Market Outlook to 2021", provides key market data on the France
Immuno Chemistry market. The report provides value, in millions of US
dollars within market segments - Anemia Tests, Vitamins Tests,
Disease Specific Immunochemistry, Endocrinology Tests,
Immunochemistry Analyzers, Immunochemistry Rapid Tests & POC, IgE
Allergy Blood Tests and Specific Proteins.
The
report also provides company shares and distribution shares data for
the market category, and global corporate-level profiles of the key
market participants. Based on the availability of data for the
particular category and country, information related to pipeline
products, news and deals is available in the report.
Extensive
interviews are conducted with industry experts to validate the market
size, company share and distribution share data and analysis.
Scope
-
Immuno Chemistry market includes Anemia Tests, Vitamins Tests,
Disease Specific Immunochemistry, Endocrinology Tests,
Immunochemistry Analyzers, Immunochemistry Rapid Tests & POC, IgE
Allergy Blood Tests and Specific Proteins.
-
Annualized market revenues (USD million) data for each of the market
categories. Data is provided from 2007 to 2014 and forecast to 2021.
-
2014 company shares and distribution shares data for Immuno Chemistry
market.
-
Global corporate-level profiles of key companies operating within the
France Immuno Chemistry market.
-
Key players covered include Siemens Healthcare, F. Hoffmann-La Roche
Ltd., Thermo Fisher Scientific Inc., Alere Inc., Ortho-Clinical
Diagnostics Inc. and Abbott Laboratories.
Reasons
to buy
-
Develop business strategies by identifying the key market segments
poised for strong growth in the future.
-
Develop market-entry and market expansion strategies.
-
Design competition strategies by identifying who-stands-where in the
market.
-
Develop investment strategies by identifying the key market segments
expected to register strong growth in the near future.
-
What are the key distribution channels and whats the most preferred
mode of product distribution - Identify, understand and capitalize.
Table
of Contents
7
Recent Developments 56
7.1
Other Significant Developments 56
7.1.1
Feb 24, 2015: SGS Expands Biomarker Analysis Services At Its
Poitiers, France, Facility 56
7.1.2
Feb 03, 2015: Fujifilm signs with the French technology research
institute BIOASTER, a joint study contract for the evaluation of a
rapid diagnostic system for the Ebola virus disease 56
7.2
Product News 57
7.2.1
Jul 22, 2015: ImmunID Key Technology Patents Covering ImmunTraCkeR
and ImmunIG Granted in the United States, Europe, Canada and Japan 57
8
Appendix 58
8.1
Research Methodology 59
8.1.1
Coverage 59
8.1.2
Secondary Research 59
8.1.3
Primary Research 59
8.1.4
Company Share Analysis 60
8.1.5
Distribution Share Analysis 60
8.2
GlobalData Consulting 60
8.3
Contact Us 60
8.4
Disclaimer 61
For More Information Kindly Contact:
ResearchMoz
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Website: http://www.researchmoz.us
Mr. Nachiket Ghumare,
Tel: +1-518-621-2074,
USA-Canada Toll Free: 866-997-4948,
Email: sales@researchmoz.us,
Website: http://www.researchmoz.us
Comments
Post a Comment